{"DataElement":{"publicId":"58215","version":"3","preferredName":"Clinical Etiology Acute Myeloid Leukemia Diagnosis Type","preferredDefinition":"a description for the cause (origin) of development of acute myeloid leukemia based on examination of a person and their medical history to identify exposure to treatments or associated risks.","longName":"C_ETIOL_AML_DX_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009817","version":"3","preferredName":"Clinical Etiology Acute Myeloid Leukemia Diagnosis","preferredDefinition":"related to the cause (origin) resulting in development of acute myeloid leukemia based on examination of a person and their medical history to identify exposure to treatments or associated risks.","longName":"C_ETIOL_AML_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2497373","version":"1","preferredName":"Clinical Etiology","preferredDefinition":"Having to do with the examination and treatment of patients.:The cause of a disease.","longName":"C25398:C16390","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1905DEFE-0A30-6098-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497371","version":"1","preferredName":"Acute Myeloid Leukemia Diagnosis","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues.  The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities 2) AML with multilineage dysplasia 3) Therapy-related AML 4) AML not otherwise categorized.  The required bone marrow or peripheral blood blast percentage for the diagnosis of AML has been recently reduced from 30% (French-American-British [FAB] classification) to 20% (WHO classification).  (WHO, 2001) -- 2003:The process of identifying a disease by the signs and symptoms.","longName":"C3171:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1905CA55-A113-5F2B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19067DE2-AA4D-5870-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015284","version":"3","preferredName":"Clinical Etiology Acute Myeloid Leukemia Diagnosis Type","preferredDefinition":"a description for the cause (origin) of development of acute myeloid leukemia based on examination of a person and their medical history to identify exposure to treatments or associated risks.","longName":"C_ETIOL_AML_DX_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MDS-related","valueDescription":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF MDS","ValueMeaning":{"publicId":"2558213","version":"1","preferredName":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF MDS","longName":"2558213","preferredDefinition":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF MDS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B072-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19087CC6-D615-0ED1-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","deletedIndicator":"No"},{"value":"Treatment related","valueDescription":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF POTENTIALLY LEUKEMOGENIC TREATMENT","ValueMeaning":{"publicId":"2558214","version":"1","preferredName":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF POTENTIALLY LEUKEMOGENIC TREATMENT","longName":"2558214","preferredDefinition":"AML RELATED TO/ASSOCIATED WITH PRIOR CLINICAL HISTORY OF POTENTIALLY LEUKEMOGENIC TREATMENT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B073-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19087CC6-D61F-0ED1-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","deletedIndicator":"No"},{"value":"de novo","valueDescription":"AML WITHOUT PRIOR CLINICAL HISTORY OF MDS OR POTENTIALLY LEUKEMOGENIC TREATMENT","ValueMeaning":{"publicId":"2558215","version":"1","preferredName":"AML WITHOUT PRIOR CLINICAL HISTORY OF MDS OR POTENTIALLY LEUKEMOGENIC TREATMENT","longName":"2558215","preferredDefinition":"AML WITHOUT PRIOR CLINICAL HISTORY OF MDS OR POTENTIALLY LEUKEMOGENIC TREATMENT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B074-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19087CC6-D629-0ED1-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","deletedIndicator":"No"},{"value":"Secondary","valueDescription":"Secondary","ValueMeaning":{"publicId":"2568473","version":"1","preferredName":"Secondary","longName":"2568473","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D886-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"GDEEN","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"75FC4C5C-D1D5-BDDC-E040-BB89AD433336","beginDate":"2009-10-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-15","modifiedBy":"ONEDATA","dateModified":"2009-10-15","deletedIndicator":"No"},{"value":"Secondary/therapy related","valueDescription":"Secondary Therapy-Related Acute Myeloid Leukemia","ValueMeaning":{"publicId":"6463734","version":"1","preferredName":"Secondary Therapy-Related Acute Myeloid Leukemia","longName":"6463734","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.: An acute myeloid leukemia arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Myeloid Leukemia Post Cytotoxic Therapy","conceptCode":"C8252","definition":"An acute myeloid leukemia arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77698CB2-D140-4F50-E053-F662850AA285","latestVersionIndicator":"Yes","beginDate":"2018-10-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-10-04","modifiedBy":"ONEDATA","dateModified":"2018-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77698CB2-D159-4F50-E053-F662850AA285","beginDate":"2018-10-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-10-04","modifiedBy":"ONEDATA","dateModified":"2018-10-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"19087CC6-D601-0ED1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"MORENOC","dateModified":"2018-10-04","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"2811806","version":"1","longName":"MDS Prev Untreated","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical Onset of AML","type":"Preferred Question Text","description":"Clinical Onset of AML","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Onset AML","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19086D9C-B47A-0ED3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}